Most recent technology transfer projects

Funding authority Programme Title Period
Crowdfunding Development of an enzyme replacement therapy for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis (FMP, Margitta Dathe and WWU, Heiko Traupe) Ongoing
Leibniz Association Leibniz-Transfer Cystein‐selective bioconjugation for next generation antibody drug conjugates (Christian Hackenberger/FMP) 03.2018 - 12.2022
Federal Ministry of Education and Research (BMBF) Targetvalidierung für die pharmazeutische Wirkstoffentwicklung Evaluating Ena/VASP as a novel relevant drug target for treatment of cancer metastasis (FMP, Ronald Kühne and University of Cologne, Hans-Günther Schmalz) 01.2018 - 04.2020
Bavarian Ministry of Economic Affairs and Media, Energy and Technology m4 Award Development of a Tubulis Technologies proprietary ADC for Acute Myeloid Leukemia treatment (Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt/LMU and Christian Hackenberger/FMP) 01.2018 - 12.2019
Federal Ministry for Economic Affairs and Energy (BMWi) EXIST Forschungstransfer I Tubulis Technologies, a pre-start-up project affiliated with the Ludwig Maximilians University Munich (LMU, Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt) and the FMP (Christian Hackenberger) 04.2017 - 09.2019
The Michael J. Fox Foundation Improved Biomarkers & Clinical Outcome Measures - Spring 2016 Program Supramolecular hosts as combined protein aggregation inhibitors and hyperpolarized MRI reporters, Leif Schröder 09.2016 - 03.2019
Human Frontier Science Program (HFSP) Program Grant Imaging cellular function noninvasively with genetically engineered reporters for hyperpolarized MRI, Leif Schröder, FMP & Mikhail Shapiro, Caltech, USA 05.2016 - 04.2019

Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)

Diese Website verwendet Cookies zur Verbesserung des inhaltlichen Angebots. Datenschutz OK